Fahr’s syndrome: a case of unwanted calcium in the brain
Fahr’s syndrome: a case of unwanted calcium in the brain
复制标题
法尔氏综合症:大脑中多余钙的情况
DOI:
10.1007/s11739-019-02119-y
复制
发表时间:
2019
影响因子:
4.6
通讯作者:
Rahul S Gandhi
中科院分区:
文献类型:
--
作者:
K. Sahu;A. Mishra;A. Lal;Rahul S Gandhi
We read with great interest, the recent article by Koratala et al. published in your esteemed journal [1]. Through our letter, we aim to discuss additional facts and newer developments with regards to Fahr’s syndrome. A 70-year-old woman with past medical history of hypertension and hyperlipidemia presented to emergency room after sustaining a mechanical fall while attempting to get up from a chair. She denied any loss of consciousness, involuntary limb movements or blurring of vision. Her vitals at presentation were normal except for high blood pressure of 150/80 mm Hg. Physical examination was unremarkable for any focal neurological deficits, fractures or lacerations. Computed tomography (CT) did not reveal any parenchymal bleed or acute intracranial process. However, there was an incidental detection of extensive calcification of the bilateral basal ganglia (BG) and cerebellum (Fig. 1a, b). Re-evaluation of the patient was done with a detailed history and physical examination. Laboratory investigations for possible causes of BG calcification such as hypoparathyroidism, hypothyroidism, heavy metal poisoning, infections, hypervitaminosis and other neurodegenerative disorders were conducted. As there was no family history of similar illness and above-mentioned blood work were normal, a final diagnosis of idiopathic basal ganglia calcification (IBGC) or Fahr’s syndrome was made. Fahr’s syndrome was named after a German pathologist in 1930. It is considered as an extremely rare neurodegenerative disorder with an approximate prevalence of less than 1/1,000,000 [2]. All cases of basal ganglia calcification (BGC) should undergo a dedicated neurological examination and a comprehensive laboratory workup. To prevent any irreversible neurological deficit, it is extremely important to not miss the treatable etiologies. Figure 2 mentions about the major categories for BGC. Hypoparathyroidism, hypothyroidism, lead poisoning, hypervitaminosis D, infections are few treatable causes which if timely diagnosed could be extremely rewarding. Once known metabolic, toxic, infectious, and endocrinologic causes are ruled out, the rarer genetic disorders such as neurofibromatosis, tuberous sclerosis, Cockyane syndrome should be considered [3, 4]. Amongst the genetic disorders, Wilson’s disease is a classical example of treatable condition and hence should be considered in all young patients with deranged liver functions and BGC. If despite extensive laboratory workup, the cause for BGC remains unclear, then the possibility of idiopathic basal ganglia calcification (IBGC), also known as bilateral striopallidodentate calcinosis, or Fahr’s syndrome should be considered [3, 4]. Primary familial brain calcification (PFBC) is a familial form of IBGC which runs in an autosomal dominant fashion. Fahr’s syndrome is idiopathic in origin and has no association with any known calcium, phosphorus or copper metabolism abnormalities. For almost a century, no major studies pertinent to pathophysiology of calcium deposition were done, however, recently researchers have claimed Fahr’s syndrome to be a dynamic disease rather than just a metastatic calcium deposition. Studies by Batla et al. and Ramos et al. showed genetic mutations in almost 50% cases of PFBC namely SLC20A2 ( ~ 40% cases), PDGFB ( ~ 11% cases), PDGFRB ( ~ 2% cases), and XPR1 ( ~ 2% cases) [5, 6]. Importance of these mutations are still a topic of research but till now, the two most important clinical associations reported are PDGFB mutations with headache, and SLC20A2 with parkinsonian features and stroke [5–7]. * Kamal Kant Sahu drkksahu85@gmail.com